Immutep (IMMP) Operating Income (2012 - 2024)
Immutep (IMMP) posted Operating Income of -$17.3 million for Q4 2024, up 43.7% on a QoQ basis from -$30.7 million in Q2 2024, and down 14.74% year-over-year from -$20.3 million in Q1 2024.
Immutep (IMMP) Operating Income (2012 - 2024) Analysis & Trends
Immutep's Operating Income history runs 9 years deep, the most recent figure standing at -$17.3 million for Q4 2024.
- Quarterly Operating Income fell 14.74% year-over-year to -$17.3 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$77.1 million (down 67.05% YoY) and the FY2024 annual result came in at -$30.7 million, changed N/A from the prior year.
- Operating Income was -$17.3 million for Q4 2024 at Immutep, up from -$30.7 million in the prior quarter.
- Across five years, Operating Income topped out at -$12.3 million in Q4 2021 and bottomed at -$30.7 million in Q2 2024.
- A 4-year average of -$17.9 million and a median of -$15.1 million in 2023 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2023 — Operating Income decreased 6.9% — and 2024, when it retreated 14.74%.
- Immutep's Operating Income stood at -$12.3 million in 2021, then retreated by 14.73% to -$14.1 million in 2022, then declined by 6.9% to -$15.1 million in 2023, then fell by 14.74% to -$17.3 million in 2024.
- Business Quant data shows IMMP's Operating Income at -$17.3 million in Q4 2024, -$30.7 million in Q2 2024, and -$15.1 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Immutep | 569.08 Mn | 569.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -17.28 Mn |
| Jun 30, 2024 | -30.68 Mn |
| Dec 31, 2023 | -15.06 Mn |
| Dec 31, 2022 | -14.08 Mn |
| Dec 31, 2021 | -12.28 Mn |
| Dec 31, 2019 | -4.74 Mn |
| Jun 30, 2019 | -14.15 Mn |
| Dec 31, 2018 | -7.17 Mn |
| Dec 31, 2016 | -3.51 Mn |
| Jun 30, 2015 | -4,973.17 |
| Dec 31, 2012 | -8.27 Mn |